The study enrolled 25 patients with high-grade bladder cancer that had come back after earlier BCG treatment. Their median ...
The phase 3 VOLGA trial looks at perioperative durvalumab plus enfortumab vedotin, with and without tremelimumab, for muscle-invasive bladder cancer.
Bladder Cancer Edition Part 2 / advanced urothelial carcinoma, Andrea Necchi, Antibody drug conjugates, Astellas, bladder ...
On October 25, 2026, OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition brought together leading oncology experts ...
MedPage Today on MSN
A Win for Durvalumab Doublet in Muscle-Invasive Bladder Cancer
EFS and OS boost with ICI plus enfortumab vedotin in cisplatin-ineligible patients ...
A retrospective cohort of 60 patients found that bladder preservation was feasible after a complete response to neoadjuvant ...
Learn about types of incontinence pads for MS, differences between bladder and menstrual pads, skin protection tips, insurance coverage, and when to seek medical help.
Georgia Lee Hampshire, 27, was taking up to 14g of a drug every day at the height of her 10-year addiction, suffering ...
A Trump administration doctor says neon yellow urine is normal because of diets consisting entirely of meat and fermented foods. Here’s what experts say ...
Moderna is rated a Hold, citing valuation concerns, lack of definitive long-term efficacy data, and significant execution and ...
A recent study published in the Journal of Urology revealed promising long-term results for ImmunityBio, Inc. IBRX and its ...
ImmunityBio reported publication of long term Phase 2/3 QUILT-3.032 data in BCG unresponsive non muscle invasive bladder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results